Biotech

All Articles

Vaccine and Keytruda combo helpful in squamous tissue carcinoma

.Immune gate inhibitors are actually the superheroes of cancer treatment. Drugs like Bristol Myers S...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings...

Regeneron's Opdualag rival reveals 57% response fee

.Regeneron is actually back along with long-term consequence for its LAG-3 prevention and PD-1 inhib...

AstraZeneca articles information on internal rivals to AbbVie, Pfizer ADCs

.AstraZeneca has shared an early look at the efficiency of its in-house antibody-drug conjugate (ADC...

iTeos- GSK's TIGIT celebrity reveals significant renovation

.After introducing a phase 3 launch based on positive midstage end results, iTeos and GSK are eventu...

More joint FDA may accelerate unusual health condition R&ampD: document

.The FDA must be even more available as well as collective to release a surge in approvals of unusua...

Zenas, MBX, Bicara scalp to Nasdaq in hot day for biotech IPOs

.It's an abnormally active Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Ther...

Atea's COVID antiviral neglects to halt hospitalizations in phase 3

.Atea Pharmaceuticals' antiviral has actually neglected another COVID-19 trial, however the biotech ...

Neurocrine's offer to spare mental illness prospect falls short

.Neurocrine Biosciences' mental illness course pivot has neglected. The biotech was unable to reprod...

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has created a late entry to the radioligand party, paying one hundred million europeans ($ 1...